NM_024063.3:c.1275+1090T>G
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_024063.3(AFG2B):c.1275+1090T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.561 in 152,044 control chromosomes in the GnomAD database, including 27,396 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.56 ( 27396 hom., cov: 32)
Consequence
AFG2B
NM_024063.3 intron
NM_024063.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.480
Publications
53 publications found
Genes affected
AFG2B (HGNC:28762): (AFG2 AAA ATPase homolog B) Predicted to enable ATP binding activity. Located in cytoplasm and spindle. [provided by Alliance of Genome Resources, Apr 2022]
AFG2B Gene-Disease associations (from GenCC):
- hearing loss, autosomal recessive 119Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- neurodevelopmental disorder with hearing loss and spasticityInheritance: AR Classification: MODERATE Submitted by: Ambry Genetics, G2P
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.98).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.886 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| AFG2B | ENST00000305560.11 | c.1275+1090T>G | intron_variant | Intron 2 of 7 | 1 | NM_024063.3 | ENSP00000305494.6 | |||
| AFG2B | ENST00000525552.1 | n.46-434T>G | intron_variant | Intron 1 of 2 | 3 | ENSP00000453091.1 | ||||
| AFG2B | ENST00000531970.5 | n.1275+1090T>G | intron_variant | Intron 2 of 7 | 2 | ENSP00000436823.1 | ||||
| AFG2B | ENST00000559860.2 | n.1335+1090T>G | intron_variant | Intron 2 of 4 | 2 |
Frequencies
GnomAD3 genomes AF: 0.560 AC: 85151AN: 151926Hom.: 27337 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
85151
AN:
151926
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.561 AC: 85274AN: 152044Hom.: 27396 Cov.: 32 AF XY: 0.567 AC XY: 42159AN XY: 74304 show subpopulations
GnomAD4 genome
AF:
AC:
85274
AN:
152044
Hom.:
Cov.:
32
AF XY:
AC XY:
42159
AN XY:
74304
show subpopulations
African (AFR)
AF:
AC:
34925
AN:
41484
American (AMR)
AF:
AC:
9483
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
AC:
1848
AN:
3470
East Asian (EAS)
AF:
AC:
4705
AN:
5182
South Asian (SAS)
AF:
AC:
2862
AN:
4824
European-Finnish (FIN)
AF:
AC:
4291
AN:
10524
Middle Eastern (MID)
AF:
AC:
164
AN:
294
European-Non Finnish (NFE)
AF:
AC:
25597
AN:
67958
Other (OTH)
AF:
AC:
1186
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1584
3169
4753
6338
7922
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
694
1388
2082
2776
3470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2548
AN:
3460
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.